J0741 HCPCS Level II Code: Injection, cabotegravir and rilpivirine, 2mg/3mg
Coding at a Glance
- Drug products
- 2 NDC products
Medicare Coverage & Payment
- CMS short descriptor: Inj, cabote rilpivir 2mg 3mg
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Drugs (pricing indicator 51)
- BETOS: O1E — Other drugs
- Last CMS action effective: October 1, 2021
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Change history
- October 1, 2021Added to the code setInjection, cabotegravir and rilpivirine, 2mg/3mg
Drug products (NDC)
CMS ASP NDC-HCPCS Crosswalk · 2026 Q3
Medicare Part B payment limit (ASP + 6%): $24.67
49702-0240-15 — Cabenuva — ViiV Healthcare Company (size 6 × qty 1 (2 MG - 3 MG per billing unit))
49702-0253-15 — Cabenuva — ViiV Healthcare Company (size 4 × qty 1 (2 MG - 3 MG per billing unit))
From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.
Contextual Map
Every relationship of J0741 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (34)
- J0701 — Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg[Sibling]
- J0702 — Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg[Sibling]
- J0703 — Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg[Sibling]
- J0706 — Injection, caffeine citrate, 5 mg[Sibling]
- J0710 — Injection, cephapirin sodium, up to 1 gm[Sibling]
- J0712 — Injection, ceftaroline fosamil, 10 mg[Sibling]
- J0713 — Injection, ceftazidime, per 500 mg[Sibling]
- J0714 — Injection, ceftazidime and avibactam, 0.5 g/0.125 g[Sibling]
- and 26 more
Change history
- October 1, 2021 — Added to the code set [Change history]
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J0741 in its code family, with their registry titles.
- J0736 — Injection, clindamycin phosphate, 300 mg
- J0737 — Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
- J0738 — Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0739 — Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0740 — Injection, cidofovir, 375 mg
- J0742 — Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
- J0743 — Injection, cilastatin sodium; imipenem, per 250 mg
- J0744 — Injection, ciprofloxacin for intravenous infusion, 200 mg
- J0745 — Injection, codeine phosphate, per 30 mg
- J0750 — Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)